Together with our findings of Aβ42-related reduction of Igf2 expression, this may help explain the pathophysiology of peripheral metabolic deficits observed in AD mouse models18 and humans diagnosed with AD82. The gene discussed is IGF2; the disease is Alzheimer disease.